SUMMARY Prerious evidence shows that salt-sensitive (S) rats have a net increase in plasma mlneralocorticoid activity due to l&-hydroxy-ll-deoxycorticosterone and decreased urinary kallikrein excretion compared to salt-resistant (R) rats. Since minermlocorticolds stimulate urinary kallikrein excretion, these results are inconsistent. This inconsistency was explained by the fact that, while R rats responded normally to treatment with deoxycorticosterone (DOC) by an Increase in urinary kallikrein excretion, S rats showed no change in urinary kallikrein even when treated with 10 mg of DOC/day for 24 days. S and R rats responded identically to DOC with changes in muscle electrolytes and relative hypertrophy of the renal distal tubule. Other measures of chronic mlneralocorticoid response in S rats beside kallikrein were, therefore, intact. It was found that S rats were capable of responding to Na deficient diet with an increase in urinary kallikrein comparable to R rats. It was argued, therefore, that mineralcocorticoid receptor mechanisms and distal-tubular cell responsiveness are intact in S rats. Mild glomerular and tubular scarring was found in S rats and the severity of renal lesions was increased by DOC treatment in S rats. These lesions correlated well with blood pressure and protelnuria. No such lesions were present in control or DOC treated R rats. It was suggested that failure of urinary kallikrein to respond to DOC in S rats may be a secondary phenomenon resulting from renal damage. AHL has selectively bred rats for sensitivity (S rats) or resistance (R rats) to the hypertensive effect of high salt diet. 1 It has been found that S rats consistently have a lower excretion rate of urinary kallikrcin activity than R rats.
D
AHL has selectively bred rats for sensitivity (S rats) or resistance (R rats) to the hypertensive effect of high salt diet. 1 It has been found that S rats consistently have a lower excretion rate of urinary kallikrcin activity than R rats. 1 
"
1 It is also known that mineralocorticoids stimulate kallikrein excretion.' 1 " The S rats have higher net plasma mineralocorticoid activity than the R 7 due to the overproduction of 18-hydroxy-11 -deoxycorticosterone.' This steroid difference is controlled by a single genetic locus 9 (called Hyp-1) which codes for the adrenal mitochondrial cytochrome P-450 that mediates the 18-and 11/9-hydroxylase reactions. 10 These two facts, higher mineralocorticoid status and lower urinary kallikrein in the S compared to the R rat, are inconsistent. Therefore, we wanted to test the responsive-The S and R rats were bred in our laboratory from animals obtained from . Twenty-four hour urine samples were collected into toluene from rats in metabolic cages. No samples had fecal contamination. During collections rats were given water but no food. Urinary kallikrein was separated from non-kallikrein esterases 4 ' n on aliquots of individual rat urines by a DEAE-Sephadex minicolumn technique, and enzyme activity was measured on the kallikrein fraction by hydrolysis of the artificial substrate a-N-p-tosyl-L-arginine methyl ester (TAME). The method has been given in detail previously. 4 Enzyme activity is expressed in TAME esterase units with one unit equal to the amount of enzyme needed to hydrolyze 1 jimole of TAME at 37°C for 1 minute at pH 8. 6 .
The relative areas (volumes) of components of the renal cortex were determined on paraffin sections stained with Lillie's aldochrome 11 using a Zeiss inte-grating eyepiece. The method has been given in detail previously. 1 * Kidneys were graded for glomerular and tubular lesions on a scale as follows: 0 = normal; 0.5 = minimal lesions; 1 = lesions occupying less than 10% of the cortex; 2 = lesions occupying 10% to 30% of the cortex; 3 = lesions occupying > 30% of the cortex. Tissues were graded without knowing their identity.
Skeletal muscle Na + and K + were measured by flame photometry on 0.75N HNO t extracts of dried, fat-extracted muscle. The technique has been described.
14 Urinary protein was measured by the procedure of Lowry et al." using bovine albumin as a standard. Blood pressure (BP) was measured by the tail microphonic method 18 on rats anesthetized with ether.
Deoxycorticosterone (DOC) was given subcutaneously as a microcrystalline suspension in sesame oil. Sodium deficient diet was purchased from ICN Nutritional Biochemicals (Cleveland). Unless otherwise stated, all rats were fed (after weaning) a standard rat chow (Wayne Lab Blox) which contains 1% NaCl.
Results
Responses to DOC (0.1 and 1.0 mg/rat/day) Six-week-old female S and R rats were injected daily with either a vehicle consisting of 0.1 ml sesame oil or vehicle containing 0.1 or 1.0 mg of DOC. Urine was collected for 24 hours on two occasions 21 and 24 days after the first injection. These two collections were pooled for each rat to reduce day to day variability and measurements made on these individual rat urine pools. The BP was taken on Day 28. Table 1 and figure 1 show that the BP in S rats was moderately higher than in R rats and was increased about 20 mm Hg by the 1.0 mg dose of DOC while it remained the same in R rats after DOC. This resulted in a significant (0.01 < p < 0.025) interaction between strain and treatment on BP in the analysis of variance. These BP changes are modest because supplemental NaCl was not administered with the DOC treatment in an attempt to minimize the BP changes and subsequent renal damage. Note that urinary pro-
Vehicle DOC DOC 01mg/day 10mg/day tein excretion is about twofold higher in S than R rats (table 1) .
The urinary excretion rate of kallikrein activity was approximately equal in control (vehicle-injected) S and R rats and was increased in a dose-dependent fashion by DOC in R rats but not in S ( fig. 1 ). The Spearman rank correlation coefficient for the dose response relationships in figure 1 was r, = 0.61 (p = 0.01) for R rats and r. = 0.03 (p = 0.46) for S rats.
Responses to DOC (10 mg/rat/day)
The protocol was the same as described above except that 10 mg/rat/day was given. In addition, the rats were killed for muscle electrolyte and kidney- (table 2 and fig. 2 ). There was a significant interaction between strain and treatment on BP; S rats excreted more protein in the urine than R, and DOC treatment significantly increased urinary protein (table 2) .
Excretion of urinary kallikrein activity ( fig. 2 ) showed a pronounced increase with DOC treatment in R rats. This increase in response to 10 mg DOC/day (1.73 fold) is comparable to that seen with 1.0 mg DOC/day (1.67 fold), suggesting that maximal stimulation in R rats was achieved by the lower dose. Urinary kallikrein changed very little in S rats, even in response to the high (10 mg) dose of DOC. Since this dose is 10-fold higher than that which gave an apparently maximal response in R rats, the result confirms the complete failure of urinary kallikrein to respond to DOC in S rats. The interaction between strain and treatment on urinary kallikrein was significant (0.01 < p < 0.025).
Although the S kidney fails to increase excretion of urinary kallikrein in response to DOC, other parameters of chronic DOC treatment were intact. Depletion of total skeletal miscle K + was comparable in S and R strains (table 2). (Total muscle K + is an accurate reflection of intracellular K + , since the extracellular K + is very small relative to the total.) Skeletal muscle Na + increased comparably in S and R. (Total skeletal muscle Na + could reflect changes in either intracellular or extracellular Na + since extracellular Na is a significant proportion, about 50% of the total.
14 )
The increase in kidney weight in response to DOC was similar in S and R rats, as was the obvious relative hypertrophy of the distal tubule, and the less pronounced increase in the size of the collecting ducts. Independent of the similar S and R hypertrophy of the distal tubule, the distal tubule in S rats occupied slightly, but significantly, less relative volume than in R. Another minor point is that tubular lumens took up significantly more relative volume in S than R rats, a reflection, perhaps, of the 20% to 30% greater urine volume in S over R (table 2) . The technique for analyzing the volumes of kidney cortical constituents yielded only relative changes. If the distal tubule hypertrophies, something else must look relatively smaller because the total volume is constrained to be 100%. This decrease is only obvious in the proximal tubule since it makes up most of the cortical volume (table 2) . Glomerular and tubular lesions were graded on a scale from 0 to 3 (see Materials and Methods). There was no lesion in any R rat (all were grade 0, both DOC-treated and control). Lesions were seen in most S rats, however, consisting of glomerular scarring, tubular collapse with thickened basement membranes, and dilated tubules containing protein ( fig.  3 ). Early vascular lesions (proliferative lesions at branch pads) were seen occasionally. These have been described in detail previously." In S rats, grades of renal cortical lesions were significantly (p < 0.001) increased in DOC-treated over vehicle-treated animals as shown by a rank ordered t test (table 3). Taking all the S rats as a group (10 mg DOC/day plus vehicle-treated), we found significant correlations among the renal lesions, urinary protein, and BP measurements. Table 4 lists the lesion grades and associated urinary protein excretion and BPs. The Spearman rank correlation coefficients (r,) calculated using the data from all 18 individual S rats were: renal lesion grade vs urinary protein r, = 0.77, p < 0.001; renal lesion grade vs blood pressure r, = 0.71, p < 0.001; blood pressure vs urinary protein r, = 0.87, p < 0.001. All S rats from the second experiment are combined, i.e., vehicle and 10 mg DOC/day treated rats (same S rats as used in tables 2 and 3). Means ± SE are given.
u FIGURE 2. Responses of urinary kailikrein excretion in S and R rats to treatment with 10 mg DOCI day for 24 days. Results were analyzed by a 2 X 2 factorial analysis of variance (ANOVA), and probabilities are given below the diagram

Responses to Sodium-Deficient Diet
Another stimulus to urinary kallikrein excretion is a sodium-deficient diet. Five-week-old S and R rats were placed on a sodium-deficient diet for 38 days. Data are given in table 5 and figure 4 . The most important finding is that S rats can respond comparably to R with an increase in the rate of excretion of urinary kallikrein activity (fig. 4) . Although S rats excreted less kallikrein than R in this as well as previous experiments, the S rats do respond to the dietary manipulation with a definite increase in urinary kallikrein. The significant interaction between strain and treatment on kallikrein seen in the DOC experiments above is now absent.
Discussion
The induction of kallikrein by mineralocorticoid is a well-known phenomenon.* 1 * This is compatible with the fact that urinary kallikrein originates from the distal tubule 1 *" 11 and that mineralocorticoid receptors have a distal tubular distribution in the kidney;" it is established that electrolyte and electrophysiological responses to mineralocorticoid occur in the distal nephron. 21 We have shown that urinary kallikrein excretion responds as expected to mineralocorticoid treatment in R rats, but that in S rats this response is absent. This could be the consequence of a mineralocorticoid receptor defect in S rats. Although Funder et al w have shown that the mineralocorticoid receptors in S and R rats have similar binding characteristics and are present in equal numbers, this does not necessarily mean that the steroid-receptor complex is translated into quantitatively equivalent physiological effects in S and R rats. However, other measurements of chronic mineralocorticoid effects besides kallikrein, namely, distal tubular hypertrophy and muscle electrolyte changes, responded identically in S and R rats. This suggests that the chronic responses occurring as a consequence of mineralocorticoid receptor binding are in- •Analysis of aldosterone data was done using a log transformation because of the unequal variances between groups. tact in both strains. The failure of S rats to respond to exogenous mineralocorticoid with an increased kallikrein excretion must not, therefore, be a failure of a receptor-mediated response. This view is strongly supported by the result that on sodium deficient diet, urinary kallikrein excretion was appropriately increased in both S and R rats. This shows that urinary kallikrein in S rats is capable of responding to a mineralocorticoid stimulus. Plasma aldosterone was increased markedly by sodium deficient diet (table 5) , and the urinary kallikrein increase is presumably a response to this increased mineralocorticoid activity. As reported previously," plasma aldosterone is lower in S than R, which is consistent with the lower plasma renin activity of S compared to R.' 1 " Implicit in the discussion above is the idea that DEAE-extractable, urinary kallikrein TAME esterase activity is a measure of kallikrein production by the distal tubule. This may not, however, be a valid assumption for the S rat. Urine of the S rat contains a protein that complexes with kallikrein. Preliminary data suggest that this complexing protein inhibits kallikrein and that it originates from plasma (Joseph and Rapp, unpublished work). It appears likely that the failure of urinary kallikrein activity to increase in the DOC-treated S rat could be the result of early renal damage (tables 3 and 4, and fig. 3 ) and increased amounts of plasma proteinase inhibitor in the urine. This possibility is compatible with the developmental patterns observed for BP, urinary protein, and urinary kallikrein in S and R rats. Young S and R rats excrete similar amounts of DEAE-extractable urinary kallikrein. The strains become divergent (S less than R) with regard to urinary kallikrein excretion concomitant with the development of hypertension and proteinuria in the S strain." In the case of feeding a sodium deficient diet changes in BP and urinary protein excretion are minimized (table 5) , which would be expected to reduce the possible inactivation of urinary kallikrein by plasma inhibitor entering the urine through damaged kidneys.
No matter what the cause of the decreased urinary kallikrein activity in S rats seen previously*" 4 or seen here in response to DOC, this decreased activity could exacerbate the development of hypertension. It has been argued* 8 that kallikrein via generation of kinins in the kidney can increase renal blood flow and sodium excretion. Decreased kallikrein action may, therefore, lead to sodium retention, which favors hypertension. This argument needs to be qualified, however, by the realization that kinin generation in the kidney is also likely to be influenced by ionic strength, pH, kininase activity, availability of kininogen, and nonkallikrein esterases as well as by kallikrein and kallikrein inhibitors.
